Related references
Note: Only part of the references are listed.Thymosin α1 and cancer: action on immune effector and tumor target cells
Enrico Garaci et al.
THYMOSINS IN HEALTH AND DISEASE I (2012)
Thymosin plus cisplatin with vinorelbine or gemcitabine for non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials
Jin Jiang et al.
THORACIC CANCER (2011)
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1
Claudia Matteucci et al.
THYMOSINS IN HEALTH AND DISEASE (2010)
Thymosin alpha 1: the regulator of regulators?
Bonifazi Pierluigi et al.
THYMOSINS IN HEALTH AND DISEASE (2010)
Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma
Michele Maio et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
From lab to bedside: emerging clinical applications of thymosin alpha(1)
Allan L. Goldstein et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma
Robert G. Gish et al.
HEPATOLOGY INTERNATIONAL (2009)
Thymosin-α1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes
Qizhi Yao et al.
IMMUNOLOGY LETTERS (2007)
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel β2-microglobulin loss-of-function in melanoma cells
Chien-Chung Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activation of IKK by thymosin α1 requires the TRAF6 signalling pathway
P Zhang et al.
EMBO REPORTS (2005)
Thymosin α 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling
L Romani et al.
BLOOD (2004)
Thymosin α1 in combination with cytokines and chemotherapy for the treatment of cancer
E Garaci et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Thymosin α1 inhibits mammary carcinogenesis in Fisher rats
TW Moody et al.
PEPTIDES (2002)
Combined treatment with thymosin-α1 and low dose interferon-α after dacarbazine in advanced melanoma
G Rasi et al.
MELANOMA RESEARCH (2000)